Adaptimmune Therapeutics Plc PEG
¿Qué es el PEG de Adaptimmune Therapeutics Plc?
El PEG de Adaptimmune Therapeutics Plc es N/A
¿Cuál es la definición de PEG?
La relación precio/ganancias al crecimiento (PEG) es la relación P / E de una acción dividida por una tasa de crecimiento prevista de sus ganancias durante un período de 5 años.
The PEG ratio is calculated by dividing the P/E ratio by the company's expected earnings growth rate in the next 5 years. Since using just the P/E ratio would make high-growth companies appear overvalued relative to others, the PEG ratio is considered to be a convenient approximation. PEG is a widely employed indicator of a stock's possible true value.
Similar to P/E ratios, a lower PEG means that the stock is undervalued more. It is favored by many over the price/earnings ratio because it also accounts for growth. The PEG ratio of 1 is sometimes said to represent a fair trade-off between the values of cost and the values of growth, indicating that a stock is reasonably valued given the expected growth. A crude analysis suggests that companies with PEG values between 0 and 1 may provide higher returns. A PEG Ratio can also be a negative number if a stock's present income figure is negative, (negative earnings) or if future earnings are expected to drop (negative growth). PEG ratios calculated from negative present earnings are viewed with skepticism as almost meaningless, other than as an indication of high investment risk.
PEG de compañías en Sector Health Care en NASDAQ en comparadas con Adaptimmune Therapeutics Plc
¿Qué hace Adaptimmune Therapeutics Plc?
adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.
Empresas con peg similar a Adaptimmune Therapeutics Plc
- Ecopetrol SA tiene PEG de N/A
- Medley Capital Corp tiene PEG de N/A
- AGNC Investment Corp tiene PEG de N/A
- Liberty Media tiene PEG de N/A
- Acacia Communications Inc tiene PEG de N/A
- Smart Sand Inc tiene PEG de N/A
- Adaptimmune Therapeutics Plc tiene PEG de N/A
- TeraGo tiene PEG de N/A
- Kennametal tiene PEG de N/A
- Telstra tiene PEG de N/A
- Oracle Services Software tiene PEG de N/A
- Hecla Mining Co tiene PEG de N/A
- Kirkland`s Inc tiene PEG de N/A